Willow vs IVIM Health: Structured follow up vs high ratings
Choosing between Willow vs IVIM Health comes down to support style and clinical signaling. Early verdict: Willow emphasizes structured digital follow-up and progress tracking while IVIM Health emphasizes clinician-guided optimization, strong third-party ratings, and lower starting cost.
Explore Willow’s structured program
How the two providers differ at a glance
Compare Willow and IVIM Health directly across program model, pricing, medication type, outcome claims, and external validation. The three most distinctive supported differences are: Willow’s emphasis on a structured progress-tracking program; IVIM’s pricing and third-party ratings; and differences in published outcome claims and compounding status.
Program model and follow-up
Willow describes itself as a telehealth-first weight management program that positions its oral GLP-1 offering as part of a structured weight management journey, emphasizing progress tracking and follow-up consultations to convert medication efficacy into longer-term outcomes. IVIM Health offers a clinician-guided GLP-1 ID protocol with weekly dose adjustments and a proprietary titration approach described as structured and personalized.
Pricing and enrollment signals
Willow lists pricing starting at 299. IVIM Health presents a lower entry price starting at $75/mo, notes a program fee of $74.99/mo, and markets a Free Month Membership with code GIFT75 plus a no-obligation free consultation (a $75 value) for new patients. IVIM also states first-month pricing distinctions and ongoing rates in its FAQ and marketing copy.
See IVIM’s free consult and membership code
Medication type and regulatory notes
Both providers reference compounded medications in their captured evidence. Willow notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. IVIM Health likewise states its compounded semaglutide and tirzepatide are not FDA-approved and have not undergone FDA review for safety, effectiveness, or quality. Both require clinician evaluation and prescriptions where applicable.
Side by side: key criteria
| Criterion | Willow | IVIM Health |
|---|---|---|
| Program focus | Telehealth-first program with progress tracking and follow-up consultations | Clinician-guided GLP-1 ID protocol with weekly adjustments |
| Starting price | Starting price: 299 | Starting price: $75/mo; Free Month with code GIFT75 |
| Third-party ratings | No third-party ratings captured | 4.9-star rating on Google and Trustpilot captured |
| Outcome claims | Emphasizes converting GLP-1 efficacy into sustainable long-term outcomes via follow-up | Claims up to 40% faster weight loss with GLP-1 ID protocol; noted as proprietary and not an independent trial |
| Compounded medication note | Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded drugs are not FDA-approved and have not undergone FDA review for safety, effectiveness or quality |
Clinical oversight and eligibility
Both platforms operate with licensed clinicians. Willow states treatment is available only when a licensed clinician determines it is medically appropriate. IVIM requires consultation and prescription from an IVIM provider and notes compounded medications are used under ongoing supervision and may not be available in all states.
Check Willow clinician oversight
Evidence and trust signals
IVIM Health includes captured claims of a 4.9-star rating on both Google and Trustpilot and references internal and published retrospective observational studies supporting its protocol outcomes, while noting those are not head-to-head randomized trials and individual results may vary. Willow’s captured evidence emphasizes program structure and tracking rather than third-party ratings; the landing page capture returned an error for a deeper read in the available evidence.
Start with Willow’s program overview
Final comparison and how to choose
Willow vs IVIM Health is primarily a choice between a structured progress-tracking telehealth program and a clinician-optimized, highly rated compounded GLP-1 service with lower starting costs. Both state compounded medications are not FDA-approved and require clinician evaluation. The providers differ most on program emphasis, pricing offers, and third-party verification.
Choose Willow if…
You want a telehealth-first oral GLP-1 program framed as a structured weight management journey with progress tracking and follow-up consultations, and you accept the captured starting price of 299.
Choose IVIM Health if…
You prioritize lower starting cost options, want a no-obligation free consultation for new patients and the Free Month Membership code GIFT75, and value IVIM’s captured dual 4.9-star ratings and clinician-guided GLP-1 ID protocol. Note IVIM’s outcome claims are proprietary and not a randomized head-to-head finding.